These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
549 related articles for article (PubMed ID: 15972345)
41. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Abraham NS; El-Serag HB; Johnson ML; Hartman C; Richardson P; Ray WA; Smalley W Gastroenterology; 2005 Oct; 129(4):1171-8. PubMed ID: 16230071 [TBL] [Abstract][Full Text] [Related]
42. Use of gastrointestinal preventive therapy among elderly persons receiving antiarthritic agents in Nova Scotia, Canada. Hartnell NR; Flanagan PS; MacKinnon NJ; Bakowsky VS Am J Geriatr Pharmacother; 2004 Sep; 2(3):171-80. PubMed ID: 15561649 [TBL] [Abstract][Full Text] [Related]
43. Prospective study of acute gastrointestinal bleeding attributable to anti-inflammatory drug ingestion in the Yorkshire region of the United Kingdom. Lim CH; Heatley RV Postgrad Med J; 2005 Apr; 81(954):252-4. PubMed ID: 15811890 [TBL] [Abstract][Full Text] [Related]
44. NICE risk factors for gastrointestinal adverse events in diclofenac users in general practice in Germany: comment on the article of Thompson et al. Zeidler H; May M; Uberall MA; Vergin H Rheumatology (Oxford); 2006 Apr; 45(4):494-5. PubMed ID: 16484292 [No Abstract] [Full Text] [Related]
45. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man. Dajani EZ; Islam K J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633 [TBL] [Abstract][Full Text] [Related]
46. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors. van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747 [TBL] [Abstract][Full Text] [Related]
47. Nonsteroidal antiinflammatory drug use among patients with GI bleeding. Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205 [TBL] [Abstract][Full Text] [Related]
48. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study. Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567 [TBL] [Abstract][Full Text] [Related]
49. Safety and patient tolerance of standard and slow-release formulations of NSAIDs. Langman M; Kong SX; Zhang Q; Kahler KH; Finch E Pharmacoepidemiol Drug Saf; 2003; 12(1):61-6. PubMed ID: 12616849 [TBL] [Abstract][Full Text] [Related]
50. Pharmacoepidemiological study of prescription pattern of analgesics, antipyretics, and nonsteroidal anti-inflammatory drugs at a tertiary health care center. Al-Homrany MA; Irshaid YM Saudi Med J; 2007 Mar; 28(3):369-74. PubMed ID: 17334461 [TBL] [Abstract][Full Text] [Related]
51. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs. Patino FG; Allison J; Olivieri J; Mudano A; Juarez L; Person S; Mikuls TR; Moreland L; Kovac SH; Saag KG Arthritis Rheum; 2003 Jun; 49(3):293-9. PubMed ID: 12794782 [TBL] [Abstract][Full Text] [Related]
52. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs]. van den Bemt BJ; Benraad HB; Rasker JJ Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414 [TBL] [Abstract][Full Text] [Related]
53. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance. Borer JS; Simon LS Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077 [TBL] [Abstract][Full Text] [Related]
54. Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines. Laine L; Connors L; Griffin MR; Curtis SP; Kaur A; Cannon CP Aliment Pharmacol Ther; 2009 Oct; 30(7):767-74. PubMed ID: 19594486 [TBL] [Abstract][Full Text] [Related]
55. Ulcers, Helicobacter pylori infection, platelets and gastrointestinal complications of non-steroidal anti-inflammatory drugs: what are the connections? McCarthy DM Eur J Surg Suppl; 2002; (587):89-99. PubMed ID: 16144207 [TBL] [Abstract][Full Text] [Related]
56. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. Schneeweiss S; Glynn RJ; Avorn J; Solomon DH J Clin Epidemiol; 2005 Jan; 58(1):98-102. PubMed ID: 15649677 [TBL] [Abstract][Full Text] [Related]